Paroxetine: Loxamine is the new funded brand
Paroxetine is used to treat major depressive disorder and some other mental health conditions.
The funded brand of paroxetine is changing from Apo-Paroxetine to Loxamine. The brand that PHARMAC currently funds is a generic medicine, so this change means a different generic brand will be funded.
Your new brand is available from 1 October 2019
- From 1 October 2019, Loxamine will be fully funded and available for patients.
- From 1 March 2020, only Loxamine will be fully funded. Apo-Paroxetine will no longer be funded.
Loxamine works the same as the other brands
- Loxamine will work in the same way as Apo-Paroxetine. Loxamine has the same active ingredient and is delivered to the body in the same way.
- Loxamine has been thoroughly evaluated by Medsafe to ensure it’s safe and works the same as the other brands.
- It’s understandable that you might have questions about changing your medicine, but you shouldn’t notice any difference when you change to Loxamine. If you have any questions or concerns about changes to medicines, you should talk with your doctor, nurse or pharmacist.
There’s more information about medicines and changes to medicines on PHARMAC’s website: The facts about generic and biosimilar medicines.
Your new brand comes in tablets
Your brand is changing to help us fund other medicines
A decision to change a medicine, especially one as important as paroxetine, isn’t taken lightly.
Our job is to make sure New Zealanders have access to the medicines they need. Making changes to medicines helps us achieve that by freeing up our limited budget to fund other medicines in the community.
Find out more
If you have any questions or concerns about changing brands, talk with your doctor, nurse or pharmacist. You can also get more information from us at email@example.com or 0800 66 00 50.
For healthcare professionals
Healthcare professionals play an important role in supporting patients through changes to their medicines. We’d like to support you as you help your patients through the changes to paroxetine.
We’ve prepared some material for you to share with people as they change brands.
Here are patient information leaflets that you can download and print.
Key points to tell your patients about Loxamine
- Loxamine has the same active ingredient (paroxetine) as the other brands. This means the new brand of medication is just as safe and works the same as the old brand. Patients shouldn’t notice any difference in how it affects them.
- Loxamine comes in tablets and will look different from Apo-Paroxetine - this will not change how well the medicine works.
- Loxamine is a brand that has previously been funded.
Last updated: 12 September 2019